Medicine and Dentistry
Doxorubicin
100%
Bladder Cancer
71%
ABC Transporter Subfamily B
71%
Multidrug Resistance
71%
Multidrug Resistance Protein 1
71%
Multidrug Resistance Associated Protein 3
57%
Multidrug Resistance Associated Protein 2
57%
Therapeutic Procedure
42%
Gene
28%
Neoplasm
28%
Disease Course
28%
Primary Tumor
28%
Drug Sensitivity
28%
Quantitative Reverse Transcription Polymerase Chain Reaction
28%
Messenger RNA
14%
Cancer Cell
14%
Cancer
14%
In Vitro
14%
Reaction Analysis
14%
Tumor Recurrence
14%
Anticarcinogen
14%
Drug Resistance
14%
Drug Response
14%
Succinate Dehydrogenase
14%
Multidrug Resistance Associated Protein
14%
Pharmacology, Toxicology and Pharmaceutical Science
Doxorubicin
100%
Bladder Cancer
71%
P-Glycoprotein
71%
Multidrug Resistance Protein 1
71%
Multidrug Resistance-Associated Protein 2
57%
Chemotherapy
28%
Disease Course
28%
Neoplasm
28%
Primary Tumor
28%
Messenger RNA
14%
Antiinfective Agent
14%
Anticarcinogen
14%
Succinate Dehydrogenase
14%
Drug Resistance
14%
Tumor Recurrence
14%
Multidrug Resistance Associated Protein
14%
Biochemistry, Genetics and Molecular Biology
Doxorubicin
100%
P-Glycoprotein
71%
Multidrug Resistance
71%
P Glycoprotein
71%
Sample
28%
Nested Gene
28%
Drug Sensitivity
28%
Cancer Cell
14%
Messenger RNA
14%
Drug Resistance
14%
Drug Response
14%
Succinate Dehydrogenase
14%
Multidrug Resistance Associated Protein
14%